160 Health International Limited

HK$3.53As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2656Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (78.53%)
Medical Distribution
Beta (5Y) —
PE TTM —
TSR TTM (91.24%)
Mkt cap HK$1.188B
ROIC (10.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.70
4.88%
(26.57%)
Hold 11|5|3|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.05
0.05
18.31%
12.14%
12.33%
16.75%
Revenue¥M
68.48
69.35
69.52
68.67
14.05%
13.77%
9.34%
2.80%
Peers (US$151.5M)
Cap (US$)
PE
258.7M
—
70.60M
—
152.6M
—
Capital
TTM
5Y
10Y
Leveragex
1.410
(0.124)
(0.116)
EBIT/Intx
0.065
1.160
0.741
Own earn%
(17.64)
(47.93)
(43.10)
Sh yield%
31.60
38.37
36.60
Owners
Insiders/Inst%
11.46
45.33
Short interest%
0.84
SBC / revenue%
1.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
20–32
$1 testx
−0.1
Incr. ROIC%
15